Single nucleotide polymorphism (SNP) targeting therapies for the treatment of huntington'S disease
US-8987222-B2 · Mar 24, 2015 · US
US10167309B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10167309-B2 |
| Application number | US-201615294602-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 14, 2016 |
| Priority date | Jul 13, 2012 |
| Publication date | Jan 1, 2019 |
| Grant date | Jan 1, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
To provide a chiral reagent or a salt thereof. The chiral reagent has following chemical formula (I). In the formula (I), G 1 and G 2 are independently a hydrogen atom, a nitro group (—NO 2 ), a halogen atom, a cyano group (—CN), a group of formula (II) or (III), or both G 1 and G 2 taken together to form a group of formula (IV).
Opening claim text (preview).
The invention claimed is: 1. A chiral reagent or a salt thereof, wherein the chiral reagent has the structure of the following chemical formula (I′): wherein G 1 is a hydrogen atom, a nitro group, a halogen atom, a cyano group, or a group of formula (II), (III) or (V), G 2 is a nitro group, a cyano group, or a group of formula (III) or (V), or both G 1 and G 2 are taken together to form a group of formula (IV), wherein G 21 to G 23 are independently a hydrogen atom, a nitro group, a halogen atom, a cyano group or C 1-3 alkyl group, wherein G 31 to G 33 are independently C 1-4 alkyl group, C 1-4 alkoxy group, C 6-14 aryl group, C 7-14 aralkyl group, C 1-4 alkyl C 6-14 aryl group, C 1-4 alkoxy C 6-14 aryl group, or C 6-14 aryl C 1-4 alkyl group, wherein G 41 to G 46 are independently a hydrogen atom, a nitro group, a halogen atom, a cyano group or C 1-3 alkyl group, wherein G 51 to G 53 are independently a hydrogen atom, a nitro group, a halogen atom, a cyano group, C 1-3 alkyl group or C 1-3 alkyloxy group. 2. The chiral reagent or a salt thereof in accordance with claim 1 , wherein G 1 is a hydrogen atom. 3. The chiral reagent or a salt thereof in accordance with claim 1 , wherein G 1 is a nitro group. 4. The chiral reagent or a salt thereof in accordance with claim 1 , wherein G 1 is a halogen atom. 5. The chiral reagent or a salt thereof in accordance with claim 1 , wherein G 1 is a cyano group. 6. The chiral reagent or a salt thereof in accordance with claim 1 , wherein G 1 is a group of formula (II). 7. The chiral reagent or a salt thereof in accordance with claim 1 , wherein G 1 is a group of formula (III). 8. The chiral reagent or a salt thereof in accordance with claim 1 , wherein G 1 is a group of formula (V). 9. The chiral reagent or a salt thereof in accordance with claim 1 , wherein G 2 is a nitro group. 10. The chiral reagent or a salt thereof in accordance with claim 1 , wherein G 2 is a cyano group. 11. The chiral reagent or a salt thereof in accordance with claim 1 , wherein G 2 is a group of formula (III). 12. The chiral reagent or a salt thereof in accordance with claim 1 , wherein G 2 is a group of formula (III), wherein G 31 to G 33 are independently C 1-4 alkyl group, C 6-14 aryl group, C 7-14 aralkyl group, C 1-4 alkyl C 6-14 aryl group, C 1-4 alkoxy C 6-14 aryl group, or C 6-14 aryl C 1-4 alkyl group. 13. The chiral reagent or a salt thereof in accordance with claim 1 , wherein G 2 is a group of formula (III), wherein G 31 to G 33 are independently C 1-4 alkyl group, C 6 aryl group, C 7-10 aralkyl group, C 1-4 alkyl C 6 aryl group, C 1-4 alkoxy C 6 aryl group, or C 6 aryl C 1-4 alkyl group. 14. The chiral reagent or a salt thereof in accordance with claim 1 , wherein G 2 is a group of formula (III), wherein G 31 to G 33 are independently C 1-4 alkyl group, or C 6 aryl group. 15. The chiral reagent or a salt thereof in accordance with claim 1 , wherein G 2 is a group of formula (III), wherein G 31 to G 33 are independently C 1-4 alkyl group. 16. The chiral reagent or a salt thereof in accordance with claim 1 , wherein G 2 is a group of formula (III), wherein G 31 and G 33 are C 6 aryl group and G 32 is C 1-4 alkyl group. 17. The chiral reagent or a salt thereof in accordance with claim 1 , wherein G 2 is a group of formula (V). 18. The chiral reagent or a salt thereof in accordance with claim 1 , wherein G 2 is a group of formula (V), wherein each of G 51 and G 52 is a hydrogen atom and G 53 is a 4-methyl group. 19. A compound having the structure of or a salt thereof. 20. A compound having the structure of or a salt thereof.
directly linked by a ring-member-to-ring-member bond · CPC title
Compounds containing boron, silicon or a metal, e.g. chelates or vitamin B12 (esters with inorganic acids C07H11/00) · CPC title
containing cyclic phosphate · CPC title
one oxygen and one nitrogen atom, e.g. guanine · CPC title
comprising a heterocyclic ring · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.